## AZO: AutoZone, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -2.9% below STRENGTH zone (4.0-10.0%); PEG 1.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($3662.46)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. AutoZone Set For Solid Quarter As Consumer Demand Rebounds: Analyst**
- Source: Sahm | 20251204T190730 | Bullish | Relevance: 100%
- JP Morgan analyst Christopher Horvers reiterated an Overweight rating on AutoZone with a $4,850 price target, citing resilient demand and improving long-term earnings power. Horvers raised near-term estimates due to stronger comparable performance and expects DIY and DIFM comps to accelerate through firmer inflation and steady demand. Despite a trimmed gross margin view due to merchandising and LIFO impact, the underlying gross margin is expected to remain flat to slightly higher.

**2. Who Owns AutoZone? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251203T142137 | Somewhat-Bullish | Relevance: 100%
- This article examines the top shareholders and recent insider trades of AutoZone, highlighting the company's status as a leading retailer of automotive replacement parts. It details the largest institutional investors, including Vanguard, BlackRock, and State Street, and notes movements by active managers and hedge funds. The article also reviews recent insider transactions, mostly small sales, and discusses what these ownership and trading patterns suggest about investor and executive confidence in AutoZone's future.

**3. AutoZone (AZO) Stock Slides as Market Rises: Facts to Know Before You Trade**
- Source: www.sharewise.com | 20251203T000658 | Neutral | Relevance: 100%
- AutoZone (AZO) stock experienced a 3.05% slide despite the broader market's rise, closing at $3,826.77. The company is set to release its earnings on December 9, 2025, with projected EPS of $32.35 and revenue of $4.64 billion. Investors are advised to consider analyst estimate revisions and AutoZone's current Zacks Rank of #3 (Hold), along with its valuation metrics like Forward P/E and PEG ratios.

**4. This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday**
- Source: Benzinga | 20251204T142354 | Bullish | Relevance: 100%
- Baird initiated coverage on AutoZone (NYSE: AZO) with an Outperform rating and a $4,500 price target. This article also highlights four other significant analyst initiations for Thursday, covering Solid Biosciences, ASP Isotopes, Paymentus Holdings, and monday.com, each receiving bullish ratings and their respective price targets. These initiations reflect Wall Street's updated outlook on several key companies.

**5. AutoZone (AZO) Q1 Earnings: Wall Street Projections for Key Metrics**
- Source: Yahoo Finance | 20251204T140933 | Somewhat-Bullish | Relevance: 100%
- Analysts project AutoZone (AZO) to report Q1 earnings of $32.22 per share, a 0.9% year-over-year decline, with revenues expected to reach $4.64 billion, an 8.3% increase. The consensus EPS estimate has seen a slight upward adjustment over the past 30 days. The article also details specific metric predictions, such as "Net Sales- Auto Parts" at $4.61 billion and "Total Auto-Zone Store" count at 7,711.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Baird | $4500 | $0 | 0% |
| 2025-11-13 | Goldman Sachs | $4262 | $4090 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Baird | init | Outperform |
| 2025-11-13 | Goldman Sachs | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 24 ($0.26M) |
| Sells | 7 ($0.83M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+1.5%)
- Blackrock Inc.: 7.7% (-0.2%)
- JPMORGAN CHASE & CO: 6.4% (+68.9%)
- State Street Corpora: 4.3% (+0.1%)
- Geode Capital Manage: 2.7% (+1.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.81 elevated, pricing in significant growth expectations. Quality metrics strong (ROA 12%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $57.4B |
| Beta | 0.41 |
| 52W Range | $3162.00 - $4388.11 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.81 |
| Forward P/E | 21.8 |
| Current P/E | 26.0 |
| YoY Growth | 19.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 2.5% to -2.9% (-5.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.8pp (needs >4.0% for momentum thesis). Underperforming sector by 3.3pp, stock-specific weakness. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram positive (2.81), confirming momentum. RSI neutral at 46. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.85% (CS: 29) | Weak |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | 2.81 | Bullish |
| vs SMA20 | 0.994x | Below |
| vs SMA50 | 0.976x | Below |
| vs SMA200 | 0.999x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $3822.66
- **Stop Loss:** $3662.46 (4.2% risk)
- **Target:** $3982.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 6
- **Position Value:** $22,935.96
- **Portfolio %:** 22.94%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $32.35 | $31.04 | -4.0% |
| 2025Q3 | $50.68 | $48.71 | -3.9% |
| 2025Q2 | $37.01 | $35.36 | -4.5% |
| 2025Q1 | $28.97 | $28.29 | -2.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*